BMG Pharma is a successful Italian company born in 2018 from the aggregation of BMG Pharma S.r.l. and Sigea S.r.l.Sigea S.r.L. was a spin-off of the University of Trieste operating in the field of biopolymers and macromolecules, and it contributed to provide the Hyaluromimethic® technology and the new injectables pipeline development.BMG Pharma is a B2B specialty pharma company specialized in development, registration and commercial partnership of innovative, state-of-the-art biotechnological products.